Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Muscle Invasive Bladder Urothelial Carcinoma × sacituzumab govitecan × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Muscle Invasive Bladder Urothelial Carcinoma 1 Glioblastoma 1

Interventions

sacituzumab govitecan 1 pembrolizumab 1 erdafitinib 1 enfortumab vedotin 1 avelumab 1 Vinblastine 1 Paclitaxel 1 Nivolumab 1 Methotrexate 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06204614 2024-01-12

Drug Screening Using IMD in Bladder Cancer

Brigham and Women's Hospital

Phase EARLY_PHASE1 Unknown

Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡